TY  - RPRT
TI  - The right to be forgotten and outstanding balance insurance: a proposition for type 1 diabetes
AU  - Van Ginckel Ans
AU  - de Meester Christophe
AU  - Vinck Imgard
AU  - Sabbe Kelly
AU  - Antunes Mendes Julien
AU  - Louis Pierre-Alexandre
AU  - Castanares-Zapatero Diego
AU  - Eyssen Marijke
AB  - KCE Reports 387C (2024)Cancer survivors and people living with chronic conditions may, on average, have an increased risk of premature death or disability. Therefore, insurance companies are sometimes reluctant to grant them outstanding balance insurance on the same terms as healthy citizens. This makes it harder for them to obtain a mortgage loan and to become property owners. In 2019, Belgium introduced a ‘right to be forgotten’, which facilitates access to outstanding balance insurance for people suffering from certain chronic diseases or cured of certain cancers, under certain conditions and after certain deadlines. KCE is responsible for reassessing the list of eligible diseases every other year based on medical advances and available scientific data.Early in 2022, KCE published a first report within this new programme, which led to more favourable conditions for certain groups of breast cancer patients in 2023. This new study aims to examine the possibility of adding type 1 diabetes to the list of eligible diseases. As this chronic condition can be kept under control but not entirely cured, deciding whether the right to be forgotten is warranted in some or all patients is not as straightforward as for cancer survivors. Based on their analysis of the data on excess mortality in several subgroups of patients with diabetes type 1, the KCE experts recommend capping the ‘excess premium’ for those with a lower risk. Alternatively, policymakers may decide to assign the right to be forgotten to this group. The report also provides some suggestions for the practical implementation of these measures. 
T2  - KCE Reports
CY  - Brussels
PY  - 2024
LA  - Engels
M3  - Right to be forgotten
PB  - Belgian Health Care Knowledge Centre (KCE)
SN  - 387C
VO  - D/2024/10.273/44
DO  - https://doi.org/10.57598/R387C
ER -